Trial · NCT04701203
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Efficacy - Primary Endpoint During the Blinded Period | TransCon PTH | 78.7 | 95% Confidence Interval 66.3 to 88.1 | Percentage of participants | |
| Efficacy - Primary Endpoint During the Blinded Period | Placebo | 4.8 | 95% Confidence Interval 0.1 to 23.8 | Percentage of participants | |
| Change From Baseline to Week 26 in HPES Symptom - Physical Domain Score | TransCon PTH | -21.01 | 95% Confidence Interval -25.41 to -16.60 | units on a scale | |
| Change From Baseline to Week 26 in HPES Symptom - Physical Domain Score | Placebo | -4.81 | 95% Confidence Interval -15.22 to 5.59 | units on a scale | |
| Change From Baseline to Week 26 in HPES Symptom - Cognitive Domain Score | TransCon PTH | -20.49 | 95% Confidence Interval -25.67 to -15.31 | units on a scale | |
| Change From Baseline to Week 26 in HPES Symptom - Cognitive Domain Score | Placebo | -6.16 | 95% Confidence Interval -15.92 to 3.60 | units on a scale | |
| Change From Baseline to Week 26 in HPES Impact - Physical Functioning Domain Score | TransCon PTH | -18.29 | 95% Confidence Interval -23.59 to -12.99 | units on a scale | |
| Change From Baseline to Week 26 in HPES Impact - Physical Functioning Domain Score | Placebo | -1.01 | 95% Confidence Interval -12.40 to 10.38 | units on a scale | |
| Change From Baseline to Week 26 in HPES Impact - Daily Life Domain Score | TransCon PTH | -17.65 | 95% Confidence Interval -22.39 to -12.91 | units on a scale | |
| Change From Baseline to Week 26 in HPES Impact - Daily Life Domain Score | Placebo | -0.36 | 95% Confidence Interval -12.19 to 11.46 | units on a scale | |
| Change From Baseline to Week 26 in SF-36 Physical Functioning Subscale Score | TransCon PTH | 5.29 | 95% Confidence Interval 3.47 to 7.10 | units on a scale | |
| Change From Baseline to Week 26 in SF-36 Physical Functioning Subscale Score | Placebo | 0.12 | 95% Confidence Interval -4.64 to 4.89 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04701203/results